BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5438397)

  • 1. [Chorionic gonadotropin (HCG) in the therapy of chronic peripheral obliterating arteriopathy (CPOA) of the lower extremities caused by arteriosclerosis].
    Bonandrini L; Mantellini E; Colombo P; Seghezzi R; Lombardo F
    Minerva Chir; 1970 Mar; 25(5):368-83. PubMed ID: 5438397
    [No Abstract]   [Full Text] [Related]  

  • 2. [Human chorionic gonadotropin in the treatment of chronic peripheral obliterative arteriosclerotic arteriopathies of the lower limbs].
    Bagliani A; Moia R
    Minerva Med; 1978 Apr; 69(19):1287-93. PubMed ID: 662155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Medical treatment of obliterating peripheral arteriopathies, especially arteriosclerosis].
    Scaffidi V
    Minerva Med; 1975 Jan; 66(2):55-65. PubMed ID: 1113917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [On the use of injectable crataegus extracts in therapy of disorders of peripheral arterial circulation in subjects with obliterating arteriopathy of the lower extremities].
    Di Renzi L; Cassone R; Lucisano V; Leggio F; Gambelli G
    Boll Soc Ital Cardiol; 1969; 14(4):577-85. PubMed ID: 5408200
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical trial of a long-acting vasodilator agent in chronic peripheral obliterating arteriopathy of a sclerotic nature].
    Gemma GB; Ghezzi P; Cavaliere P
    Minerva Cardioangiol; 1969 May; 17(5):324-32. PubMed ID: 5785730
    [No Abstract]   [Full Text] [Related]  

  • 6. [ON THE CORRELATIONS BETWEEN BLOOD COAGULATION AND LIPID METABOLISM IN CHRONIC PERIPHERAL ARTERIOPATHY OF AN ARTERIOSCLEROTIC NATURE].
    VERGANI G; SIDERI GC; BERNARDI R
    Minerva Med; 1963 Sep; 54():2469-71. PubMed ID: 14057228
    [No Abstract]   [Full Text] [Related]  

  • 7. [Blood chemical changes due to lipid metabolism induced by chorionic gonadotropin. (Experimental study)].
    Bonandrini L; Mantellini E; Colombo P
    Chir Ital; 1967 Dec; 19(6):1427-39. PubMed ID: 5191721
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on drug controlled blood distribution as a conservative therapeutic principle in arteriosclerosis obliterans].
    Mörl H; Preuss EG; Bartusch M; Schneider W
    Z Kreislaufforsch; 1972 Feb; 61(2):144-52. PubMed ID: 5026177
    [No Abstract]   [Full Text] [Related]  

  • 9. [Action of chorionic gonadotropin on some serum lipid indices in atherosclerotic subjects].
    Pompei A; Belloni L; Traverso E
    Arch Maragliano Patol Clin; 1968; 24(6):729-41. PubMed ID: 5757341
    [No Abstract]   [Full Text] [Related]  

  • 10. [Taurine in the therapy of obliterating arteriopathy of the lower extremities. II. Hemoximetric changes in various evolutive stages].
    Zanelli G; Quaglia A; Zino P
    Minerva Cardioangiol; 1971 Nov; 19(11):616-9. PubMed ID: 5128423
    [No Abstract]   [Full Text] [Related]  

  • 11. [Blood lipids and glucose tolerance in 100 patients with arteriosclerotic occlusions in the lower extremities].
    Beyrer K; May R; Sailer S
    Wien Klin Wochenschr; 1968 May; 80(20):392-4. PubMed ID: 5728030
    [No Abstract]   [Full Text] [Related]  

  • 12. [Short-term heparin therapy in obliterating arteriopathies of the lower limbs].
    Arrigo F; Coglitore S; Giannetto M; Bramanti O; Barbera C; Consolo F
    Boll Soc Ital Cardiol; 1977; 22(3):273-82. PubMed ID: 617274
    [No Abstract]   [Full Text] [Related]  

  • 13. [Blood lipids and atherosclerosis].
    Martinelli M
    Bull Sci Med (Bologna); 1967; 139(4):454-60. PubMed ID: 5606045
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of polidez for treating patients with endarteritis obliterans of the lower extremities].
    Litmanovich KI; Shcherbinina SP; Mikhaĭlova LG
    Vestn Khir Im I I Grek; 1975 Oct; 115(10):62-67. PubMed ID: 1198827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Research on thrombogenesis in chronic obliterating arteriopathies of the extremities].
    Stăncioiu N; Scrobohaci ML
    Med Interna (Bucur); 1973 Aug; 25(8):963-79. PubMed ID: 4793915
    [No Abstract]   [Full Text] [Related]  

  • 16. [Taurine in the therapy of obliterating arteriopathy of the lower extremities. I. Clinical results in various evolutive phases].
    Zanelli G; Ferrero S; Patrone P
    Minerva Cardioangiol; 1971 Nov; 19(11):605-15. PubMed ID: 5128422
    [No Abstract]   [Full Text] [Related]  

  • 17. [Arteriosclerosis indices of lipid and lipoprotein metabolism].
    Reuter W; Herrmann W; Voigt H; Köhler H; Schütz C; Hanf S; Lindhofer HG; Kuklinski B
    Z Arztl Fortbild (Jena); 1984; 78(6):239-41. PubMed ID: 6730538
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of Sadamin on lipid metabolism in patients with obliterative arteriosclerosis of lower limbs].
    Kiersnowska B; Bielawiec M; Lukjan H; Grabowski R; Korfel B
    Pol Tyg Lek; 1972 Jan; 27(4):133-5. PubMed ID: 5010169
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of lipid-cholesterol metabolism in 100 patients with chronic arteriopathy of the limbs, 100 coronary patients and 100 normal patients].
    MATHIVAT A; CLEMENT D; RANGLARET A; CRABIE P
    Rev Atheroscler; 1962; 4():50-69. PubMed ID: 13933640
    [No Abstract]   [Full Text] [Related]  

  • 20. [Changes in lipid metabolism in patients with peritonitis].
    Fedorov VD
    Khirurgiia (Mosk); 1973 Oct; 49(10):131-5. PubMed ID: 4776976
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.